-
1
-
-
0038779278
-
3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
-
Setola V., Hufeisen S.J., Grande-Allen K.J., Vesely I., Glennon R.A., Blough B., Rothman R.B., and Roth B.L. 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 63 (2003) 1223-1229
-
(2003)
Mol Pharmacol
, vol.63
, pp. 1223-1229
-
-
Setola, V.1
Hufeisen, S.J.2
Grande-Allen, K.J.3
Vesely, I.4
Glennon, R.A.5
Blough, B.6
Rothman, R.B.7
Roth, B.L.8
-
2
-
-
35348877226
-
-
European Monitoring Centre for Drugs and Drug Addiction. Annual report 2005: the state of the drugs problem in Europe. Available at: http://annualreport.emcdda.eu.int. Accessed July 20, 2006.
-
-
-
-
3
-
-
35348895981
-
-
Multidisciplinary Association for Psychedelic Studies. MDMA research information: clinical research. Available at: http://www.maps.org/mdma/#clinical. Accessed June 20, 2006.
-
-
-
-
4
-
-
0142008980
-
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
-
Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., Nihoyannopoulos P., Otto C.M., Quinones M.A., Rakowski H., et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
-
(2003)
J Am Soc Echocardiogr
, vol.16
, pp. 777-802
-
-
Zoghbi, W.A.1
Enriquez-Sarano, M.2
Foster, E.3
Grayburn, P.A.4
Kraft, C.D.5
Levine, R.A.6
Nihoyannopoulos, P.7
Otto, C.M.8
Quinones, M.A.9
Rakowski, H.10
-
5
-
-
0033039361
-
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
-
Singh J.P., Evans J.C., Levy D., Larson M.G., Freed L.A., Fuller D.L., Lehman B., and Benjamin E.J. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83 (1999) 897-902
-
(1999)
Am J Cardiol
, vol.83
, pp. 897-902
-
-
Singh, J.P.1
Evans, J.C.2
Levy, D.3
Larson, M.G.4
Freed, L.A.5
Fuller, D.L.6
Lehman, B.7
Benjamin, E.J.8
-
6
-
-
0031567756
-
Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997
-
Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. Morbid Mortal Wkly Rep 46 (1997) 1061-1066
-
(1997)
Morbid Mortal Wkly Rep
, vol.46
, pp. 1061-1066
-
-
-
7
-
-
11144354035
-
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
-
Van Camp G., Flamez A., Cosyns B., Weytjens C., Muyldermans L., Van Zandijcke M., De Sutter J., Santens P., Decoodt P., Moerman C., and Schoors D. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 363 (2004) 1179-1183
-
(2004)
Lancet
, vol.363
, pp. 1179-1183
-
-
Van Camp, G.1
Flamez, A.2
Cosyns, B.3
Weytjens, C.4
Muyldermans, L.5
Van Zandijcke, M.6
De Sutter, J.7
Santens, P.8
Decoodt, P.9
Moerman, C.10
Schoors, D.11
-
8
-
-
33845974147
-
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
-
Zanettini R., Antonini A., Gatto G., Gentile R., Tesei S., and Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 356 (2007) 39-46
-
(2007)
N Engl J Med
, vol.356
, pp. 39-46
-
-
Zanettini, R.1
Antonini, A.2
Gatto, G.3
Gentile, R.4
Tesei, S.5
Pezzoli, G.6
-
9
-
-
33845986031
-
Dopamine agonists and the risk of cardiac-valve regurgitation
-
Schade R., Andersohn F., Suissa S., Haverkamp W., and Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356 (2007) 29-38
-
(2007)
N Engl J Med
, vol.356
, pp. 29-38
-
-
Schade, R.1
Andersohn, F.2
Suissa, S.3
Haverkamp, W.4
Garbe, E.5
-
10
-
-
0033989494
-
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine
-
Fitzgerald L.W., Burn T.C., Brown B.S., Patterson J.P., Corjay M.H., Valentine P.A., Sun J.H., Link J.R., Abbaszade I., Hollis J.M., et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57 (2000) 75-81
-
(2000)
Mol Pharmacol
, vol.57
, pp. 75-81
-
-
Fitzgerald, L.W.1
Burn, T.C.2
Brown, B.S.3
Patterson, J.P.4
Corjay, M.H.5
Valentine, P.A.6
Sun, J.H.7
Link, J.R.8
Abbaszade, I.9
Hollis, J.M.10
-
11
-
-
0028785126
-
Valve strands are strongly associated with systemic embolization: a transesophageal echocardiographic study
-
Freedberg R.S., Goodkin G.M., Perez J.L., Tunick P.A., and Kronzon I. Valve strands are strongly associated with systemic embolization: a transesophageal echocardiographic study. J Am Coll Cardiol 26 (1995) 1709-1712
-
(1995)
J Am Coll Cardiol
, vol.26
, pp. 1709-1712
-
-
Freedberg, R.S.1
Goodkin, G.M.2
Perez, J.L.3
Tunick, P.A.4
Kronzon, I.5
-
12
-
-
0032455270
-
Course of valvular strands in patients with stroke: cooperative study with transesophageal echocardiography
-
Nighoghossian N., Derex L., Perinetti M., Honnorat J., Barthelet M., Loire R., Adeleine P., Dayoub M.G., Servan E., Moreau T., et al. Course of valvular strands in patients with stroke: cooperative study with transesophageal echocardiography. Am Heart J 136 (1998) 1065-1069
-
(1998)
Am Heart J
, vol.136
, pp. 1065-1069
-
-
Nighoghossian, N.1
Derex, L.2
Perinetti, M.3
Honnorat, J.4
Barthelet, M.5
Loire, R.6
Adeleine, P.7
Dayoub, M.G.8
Servan, E.9
Moreau, T.10
|